Advanced search
Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 125, 2019 - Issue 1
Submit an article Journal homepage
289
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Obestatin protects and reverses nonalcoholic fatty liver disease and its associated insulin resistance in rats via inhibition of food intake, enhancing hepatic adiponectin signaling, and blocking ghrelin acylation

Eman F. KhaleelDepartment of Medical Physiology, College of Medicine, King Khalid University, Abha, Saudi Arabia; ;Department of Medical Physiology, Faculty of Medicine, Cairo University, Cairo, Egypt; Correspondence[email protected]
View further author information
&
Ghada A. Abdel-AleemDepartment of Medical Biochemistry, College of Medicine, King Khalid University, Abha, Saudi Arabia; ;Department of Medical Biochemistry, Faculty of Medicine, Tanta University, Tanta, EgyptView further author information
Pages 64-78 | Received 11 Dec 2017, Accepted 03 Feb 2018, Published online: 10 Feb 2018

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related Research Data

Obestatin protects and reverses nonalcoholic fatty liver disease and its associated insulin resistance in rats via inhibition of food intake, enhancing hepatic adiponectin signaling, and blocking ghrelin acylation
Source: Figshare
Obestatin protects and reverses nonalcoholic fatty liver disease and its associated insulin resistance in rats via inhibition of food intake, enhancing hepatic adiponectin signaling, and blocking ghrelin acylation
Source: Figshare

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.